Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Archifar 500 mg powder for solution for injection or infusion.
Archifar 1g powder for solution for injection or infusion.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection or infusion. A white to light yellow crystalline powder. |
Each vial contains meropenem trihydrate equivalent to anhydrous meropenem 500mg and 1g, respectively.
Excipient with known effect: sodium.
Each 500 mg vial contains 104 mg sodium carbonate which equates to approximately 2.0 mEq of sodium (approximately 45 mg).
Each 1 g vial contains 208 mg sodium carbonate which equates to approximately 4.0 mEq of sodium (approximately 90 mg).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Meropenem |
Meropenem exerts its bactericidal activity by inhibiting bacterial cell wall synthesis in Gram-positive and Gram-negative bacteria through binding to penicillin-binding proteins (PBPs). |
| List of Excipients |
|---|
|
Sodium carbonate |
Type I clear glass vials of 20ml and 30ml. Packs of 1, 10, 25, 50 and 100 vials are available.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
500mg: 20809
1g: 20810
500mg: 23/11/2010
1g: 24/11/2010
| Drug | Countries | |
|---|---|---|
| ARCHIFAR | Cyprus, Spain, Croatia, Malta, Romania, Singapore, Tunisia |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
